Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

NORCROSS, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal ...

The encouraging aspect of this disease is that it is completely reversible, especially when identified early, and doesn't ...

Cirrhosis is a severe form of liver scarring that may increase your risk of complications and dying. There’s no cure for cirrhosis, but a doctor may recommend a liver transplant surgery if you have ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by ...

In a recent development for liver disease treatment, a new clinical trial has found that a popular weight-loss drug called Wegovy, which helps people lose weight by reducing their appetite and slowing ...

Researchers at University of California San Diego School of Medicine have developed a new, easy-to-use blood test score that ...

Steatotic liver disease is an increasingly recognised comorbidity linked to HIV treatment.

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

HIV status linked to distinct immune signatures tied to persistent portal hypertension after HCV cure in advanced cirrhosis.

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

ViiV Healthcare has announced new 96‑week findings from a sub‑group analysis of the PASO DOBLE study, showing that adults ...